Bone Mineral Density in Patients With Sarcoidosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06238037

Enrollment

144

Registered

2024-02-02

Start date

2019-12-01

Completion date

2024-04-30

Last updated

2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis Risk, Sarcoidosis

Brief summary

To assess the frequency and risk factors of decreased bone mineral density (BMD) and vertebral fractures in Danish patients with sarcoidosis.

Detailed description

An increased risk of bone fracture has been found in patients with sarcoidosis. Some data showed that the risk of fracture was limited to patients treated with glucocorticoid but data are conflicting and not all studies can prove an increased risk of fracture or bone mineral loss in sarcoidosis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of sarcoidosis * Signed informed consent

Exclusion criteria

* Inability or unwillingness to adhere to the study * Inability to give informed consent

Design outcomes

Primary

Measure	Time frame	Description
Number of patients with osteoporosis	At baseline	Mean BMD at baseline and the distribution of osteopenia osteoporosis and normal scans
Number of patients with osteopenia	At baseline	Mean BMD at baseline and the distribution of osteopenia osteoporosis and normal scans

Secondary

Measure	Time frame	Description
Number of participants with vertebral fracture	At baseline	Proportion of patients with vertebral fracture

Countries

Denmark

Outcome results